Concepedia

Author

Michael Findlay

University of AucklandORCID

Also Known As

Bruna Angelelli, Findlay, Michael, J Cebon, Jacob Frick, M FINDLAY, M Findlay, M. FINDLAY, M. Findlay, M. P. Findlay, M.P. Findlay

172

Publications

7.3K

Citations

39

H-Index

90

Concepts

All Affiliations

University of AucklandClinical Trials New ZealandThe University of SydneyAuckland City HospitalUniversity of Otago
MF

About

Michael Findlay is an author at University of Auckland specializing in medicine, oncology, and radiation oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

17

22

1.1K

2

Health Sciences

6

6

427

3

Nursing

2

2

144

4

Education

1

1

30

5

Engineering

1

1

14

Michael Findlay

×

52

Publications

5.1K

Citations

30

H-Index

YearCitations

Oxaliplatin Combined With Weekly Bolus Fluorouracil and Leucovorin As Surgical Adjuvant Chemotherapy for Stage II and III Colon Cancer: Results From NSABP C-07

J. Philip Kuebler, H. Samuel Wieand, Michael J. O’Connell,

Journal of Clinical Oncology

2007

1K

First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials

Harpreet Wasan, Peter Gibbs, Navesh Sharma,

The Lancet Oncology

2017

378

SIRFLOX: Randomized Phase III Trial Comparing First-Line mFOLFOX6 (Plus or Minus Bevacizumab) Versus mFOLFOX6 (Plus or Minus Bevacizumab) Plus Selective Internal Radiation Therapy in Patients With Metastatic Colorectal Cancer

Guy A. Van Hazel, Volker Heinemann, Navesh Sharma,

Journal of Clinical Oncology

2016

339

Capecitabine, an Oral Fluoropyrimidine Carbamate With Substantial Activity in Advanced Colorectal Cancer: Results of a Randomized Phase II Study

Eric Van Cutsem, Michael Findlay, B Osterwalder,

Journal of Clinical Oncology

2000

322

Noninvasive monitoring of tumor metabolism using fluorodeoxyglucose and positron emission tomography in colorectal cancer liver metastases: correlation with tumor response to fluorouracil.

Michael Findlay, Helen Young, David Cunningham,

Journal of Clinical Oncology

1996

312

E-cadherin germline mutations define an inherited cancer syndrome dominated by diffuse gastric cancer

Parry Guilford, Justin Hopkins, William M. Grady,

Human Mutation

1999

280

A phase II study in advanced gastro-esophageal cancer using epirubicin and cisplatin in combination with continuous infusion 5-fluorouracil (ECF)

Michael Findlay, David Cunningham, A. Norman,

Annals of Oncology

1994

259

TOPGEAR: A Randomized, Phase III Trial of Perioperative ECF Chemotherapy with or Without Preoperative Chemoradiation for Resectable Gastric Cancer: Interim Results from an International, Intergroup Trial of the AGITG, TROG, EORTC and CCTG

Trevor Leong, B. Mark Smithers, Karin Haustermans,

Annals of Surgical Oncology

2017

234

Capecitabine (Xeloda™) improves medical resource use compared with 5-fluorouracil plus leucovorin in a phase III trial conducted in patients with advanced colorectal carcinoma

Chris Twelves, Michael Boyer, Michael Findlay,

European Journal of Cancer

2001

159

What Do Patients Want?

Michael J. Solomon, Chet K Pager, Anil Keshava,

Diseases of the Colon & Rectum

2003

130

Page 1